;PMID: 11107105
;source_file_2881.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..41] = [t:0..41]
;1)sentence:[e:47..144] = [t:47..144]
;2)section:[e:148..240] = [t:148..240]
;3)section:[e:244..375] = [t:244..375]
;4)sentence:[e:379..390] = [t:379..390]
;5)sentence:[e:391..476] = [t:391..476]
;6)sentence:[e:477..670] = [t:477..670]
;7)sentence:[e:671..681] = [t:671..681]
;8)sentence:[e:682..1023] = [t:682..1023]
;9)sentence:[e:1024..1048] = [t:1024..1048]
;10)sentence:[e:1049..1330] = [t:1049..1330]
;11)section:[e:1331..1362] = [t:1331..1362]
;12)section:[e:1366..1411] = [t:1366..1411]

;section 0 Span:0..41
;Med Pediatr Oncol.  2000 Dec;35(6):512-5.
(SEC
  (FRAG (NNP:[0..3] Med) (NNP:[4..11] Pediatr) (NNP:[12..17] Oncol)
        (.:[17..18] .) (CD:[20..24] 2000) (.:[25..31] Dec;35)
        (-LRB-:[31..32] -LRB-) (CD:[32..33] 6) (-RRB-:[33..34] -RRB-)
        (::[34..35] :) (CD:[35..40] 512-5) (.:[40..41] .)))

;sentence 1 Span:47..144
;Identification of a 1-megabase consensus region of deletion at 1p36.3 in
;primary  neuroblastomas.
;[98..106]:variation-type:"deletion"
;[110..116]:variation-location:"1p36.3"
;[120..127]:malignancy-clinical-stage:"primary"
;[129..143]:malignancy-type:"neuroblastomas"
(SENT
  (NP-HLN
    (NP (NN:[47..61] Identification))
    (PP (IN:[62..64] of)
      (NP
        (NP (DT:[65..66] a) (NN:[67..77] 1-megabase) (NN:[78..87] consensus)
            (NN:[88..94] region))
        (PP (IN:[95..97] of)
          (NP (NN:[98..106] deletion)))))
    (PP-LOC (IN:[107..109] at)
      (NP (NN:[110..116] 1p36.3)))
    (PP-LOC (IN:[117..119] in)
      (NP (JJ:[120..127] primary) (NNS:[129..143] neuroblastomas)))
    (.:[143..144] .)))

;section 2 Span:148..240
;Hogarty MD, Liu X, Guo C, Thompson PM, Weiss MJ, White PS, Sulman EP, Brodeur
; GM, Maris JM.
(SEC
  (FRAG (NNP:[148..155] Hogarty) (NNP:[156..158] MD) (,:[158..159] ,)
        (NNP:[160..163] Liu) (NNP:[164..165] X) (,:[165..166] ,)
        (NNP:[167..170] Guo) (NNP:[171..172] C) (,:[172..173] ,)
        (NNP:[174..182] Thompson) (NNP:[183..185] PM) (,:[185..186] ,)
        (NNP:[187..192] Weiss) (NNP:[193..195] MJ) (,:[195..196] ,)
        (NNP:[197..202] White) (NNP:[203..205] PS) (,:[205..206] ,)
        (NNP:[207..213] Sulman) (NNP:[214..216] EP) (,:[216..217] ,)
        (NNP:[218..225] Brodeur) (NNP:[227..229] GM) (,:[229..230] ,)
        (NNP:[231..236] Maris) (NNP:[237..239] JM) (.:[239..240] .)))

;section 3 Span:244..375
;Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, 
;Pennsylvania 19104-4318, USA. hogartym@email.chop.edu
(SEC
  (FRAG (NNP:[244..252] Division) (IN:[253..255] of) (NNP:[256..264] Oncology)
        (,:[264..265] ,) (DT:[266..269] The) (NNP:[270..278] Children)
        (POS:[278..280] 's) (NNP:[281..289] Hospital) (IN:[290..292] of)
        (NNP:[293..305] Philadelphia) (,:[305..306] ,)
        (NNP:[307..319] Philadelphia) (,:[319..320] ,)
        (NNP:[322..334] Pennsylvania) (CD:[335..345] 19104-4318)
        (,:[345..346] ,) (NNP:[347..350] USA) (.:[350..351] .)
        (NNP:[352..366] hogartym@email) (.:[366..375] .chop.edu)))

;sentence 4 Span:379..390
;BACKGROUND:
(SENT
  (NP (NN:[379..389] BACKGROUND) (::[389..390] :)))

;sentence 5 Span:391..476
;Deletion of the distal short arm of chromosome 1 occurs frequently  in
;neuroblastoma.
;[391..399]:variation-type:"Deletion"
;[407..439]:variation-location:"distal short arm of chromosome 1"
;[462..475]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[391..399] Deletion))
      (PP (IN:[400..402] of)
        (NP
          (NP (DT:[403..406] the) (JJ:[407..413] distal) (JJ:[414..419] short)
              (NN:[420..423] arm))
          (PP (IN:[424..426] of)
            (NP (NN:[427..437] chromosome) (CD:[438..439] 1))))))
    (VP (VBZ:[440..446] occurs)
      (ADVP-TMP (RB:[447..457] frequently))
      (PP (IN:[459..461] in)
        (NP (NN:[462..475] neuroblastoma))))
    (.:[475..476] .)))

;sentence 6 Span:477..670
;In addition, neuroblastoma has been described in children with 
;constitutional deletions within 1p36, supporting the existence of one or more
; neuroblastoma suppressor genes within this region.
;[490..503]:malignancy-type:"neuroblastoma"
;[526..534]:malignancy-developmental-state:"children"
;[556..565]:variation-type:"deletions"
;[573..577]:variation-location:"1p36"
;[620..650]:gene-rna:"neuroblastoma suppressor genes"
(SENT
  (S
    (PP (IN:[477..479] In)
      (NP (NN:[480..488] addition)))
    (,:[488..489] ,)
    (NP-SBJ-1 (NN:[490..503] neuroblastoma))
    (VP (VBZ:[504..507] has)
      (VP (VBN:[508..512] been)
        (VP (VBN:[513..522] described)
          (NP-1 (-NONE-:[522..522] *))
          (PP (IN:[523..525] in)
            (NP
              (NP (NNS:[526..534] children))
              (PP (IN:[535..539] with)
                (NP
                  (NP (JJ:[541..555] constitutional) (NNS:[556..565] deletions))
                  (PP-LOC (IN:[566..572] within)
                    (NP (NN:[573..577] 1p36)))))))
          (,:[577..578] ,)
          (S-ADV
            (NP-SBJ (-NONE-:[578..578] *))
            (VP (VBG:[579..589] supporting)
              (NP
                (NP (DT:[590..593] the) (NN:[594..603] existence))
                (PP (IN:[604..606] of)
                  (NP
                    (NP
                      (QP (CD:[607..610] one) (CC:[611..613] or)
                          (JJR:[614..618] more))
                      
                      (NML (NN:[620..633] neuroblastoma)
                           (NN:[634..644] suppressor))
                      (NNS:[645..650] genes))
                    (PP-LOC (IN:[651..657] within)
                      (NP (DT:[658..662] this) (NN:[663..669] region)))))))))))
    (.:[669..670] .)))

;sentence 7 Span:671..681
;PROCEDURE:
(SENT
  (NP (NN:[671..680] PROCEDURE) (::[680..681] :)))

;sentence 8 Span:682..1023
;We have pursued a  1p36 tumor suppressor gene identification strategy that
;has included deletion  mapping of 566 primary neuroblastomas and 46
;neuroblastoma-derived cell lines,  and have determined the parental origin of
;the deleted 1p homologue in 44 cases  to determine whether there is evidence
;for genomic imprinting within this  region.
;[701..727]:gene-rna:"1p36 tumor suppressor gene"
;[770..778]:variation-type:"deletion"
;[795..802]:malignancy-clinical-stage:"primary"
;[803..817]:malignancy-type:"neuroblastomas"
;[825..838]:malignancy-type:"neuroblastoma"
;[907..914]...[918..927]:variation-type:"deleted"..."homologue"
;[915..917]:variation-location:"1p"
(SENT
  (S
    (NP-SBJ (PRP:[682..684] We))
    (VP
      (VP (VBP:[685..689] have)
        (VP (VBN:[690..697] pursued)
          (NP
            (NP (DT:[698..699] a)
               (NN:[701..705] 1p36)
              (NML
                (NML (NN:[706..711] tumor) (NN:[712..722] suppressor))
                (NN:[723..727] gene))
              (NN:[728..742] identification) (NN:[743..751] strategy))
            (SBAR
              (WHNP-1 (WDT:[752..756] that))
              (S
                (NP-SBJ-1 (-NONE-:[756..756] *T*))
                (VP (VBZ:[757..760] has)
                  (VP (VBN:[761..769] included)
                    (NP
                      (NP (NN:[770..778] deletion) (NN:[780..787] mapping))
                      (PP (IN:[788..790] of)
                        (NP
                          (NP (CD:[791..794] 566) (JJ:[795..802] primary)
                              (NNS:[803..817] neuroblastomas))
                          (CC:[818..821] and)
                          (NP (CD:[822..824] 46)
                            (ADJP (NN:[825..838] neuroblastoma)
                                  (HYPH:[838..839] -) (VBN:[839..846] derived))
                            (NN:[847..851] cell) (NNS:[852..857] lines))))))))))))
      (,:[857..858] ,) (CC:[860..863] and)
      (VP (VBP:[864..868] have)
        (VP (VBN:[869..879] determined)
          (NP
            (NP (DT:[880..883] the) (JJ:[884..892] parental)
                (NN:[893..899] origin))
            (PP (IN:[900..902] of)
              (NP (DT:[903..906] the) (VBN:[907..914] deleted)
                  (NN:[915..917] 1p) (NN:[918..927] homologue))))
          (PP (IN:[928..930] in)
            (NP (CD:[931..933] 44) (NNS:[934..939] cases)))
          (S-ADV
            (NP-SBJ (-NONE-:[939..939] *))
            (VP (TO:[941..943] to)
              (VP (VB:[944..953] determine)
                (SBAR (IN:[954..961] whether)
                  (S
                    (NP-SBJ (EX:[962..967] there))
                    (VP (VBZ:[968..970] is)
                      (NP-PRD
                        (NP (NN:[971..979] evidence))
                        (PP (IN:[980..983] for)
                          (NP (JJ:[984..991] genomic)
                              (NN:[992..1002] imprinting)))
                        (PP-LOC (IN:[1003..1009] within)
                          (NP (DT:[1010..1014] this) (NN:[1016..1022] region)))))))))))))
    (.:[1022..1023] .)))

;sentence 9 Span:1024..1048
;RESULTS AND CONCLUSIONS:
(SENT
  (NP (NNS:[1024..1031] RESULTS) (CC:[1032..1035] AND)
      (NNS:[1036..1047] CONCLUSIONS) (::[1047..1048] :)))

;sentence 10 Span:1049..1330
;We have identified a 1-Mb consensus region of  deletion within 1p36.3 defined
;by primary tumor deletions, constructed a  physical map of the region that is
;being sequenced to completion, and have  identified and prioritized candidate
;genes within this region for further  analyses.
;[1096..1104]:variation-type:"deletion"
;[1112..1118]:variation-location:"1p36.3"
;[1130..1137]:malignancy-clinical-stage:"primary"
;[1138..1143]:malignancy-type:"tumor"
;[1144..1153]:variation-type:"deletions"
(SENT
  (S
    (NP-SBJ (PRP:[1049..1051] We))
    (VP
      (VP (VBP:[1052..1056] have)
        (VP
          (VP (VBN:[1057..1067] identified)
            (NP
              (NP
                (NP (DT:[1068..1069] a) (NN:[1070..1074] 1-Mb)
                    (NN:[1075..1084] consensus) (NN:[1085..1091] region))
                (PP (IN:[1092..1094] of)
                  (NP (NN:[1096..1104] deletion)))
                (PP-LOC (IN:[1105..1111] within)
                  (NP (NN:[1112..1118] 1p36.3))))
              (VP (VBN:[1119..1126] defined)
                (NP (-NONE-:[1126..1126] *))
                (PP (IN:[1127..1129] by)
                  (NP-LGS (JJ:[1130..1137] primary) (NN:[1138..1143] tumor)
                          (NNS:[1144..1153] deletions))))))
          (,:[1153..1154] ,)
          (VP (VBN:[1155..1166] constructed)
            (NP
              (NP (DT:[1167..1168] a) (JJ:[1170..1178] physical)
                  (NN:[1179..1182] map))
              (PP (IN:[1183..1185] of)
                (NP
                  (NP (DT:[1186..1189] the) (NN:[1190..1196] region))
                  (SBAR
                    (WHNP-1 (WDT:[1197..1201] that))
                    (S
                      (NP-SBJ-1 (-NONE-:[1201..1201] *T*))
                      (VP (VBZ:[1202..1204] is)
                        (VP (VBG:[1205..1210] being)
                          (VP (VBN:[1211..1220] sequenced)
                            (NP-1 (-NONE-:[1220..1220] *))
                            (PP (TO:[1221..1223] to)
                              (NP (NN:[1224..1234] completion))))))))))))))
      (,:[1234..1235] ,) (CC:[1236..1239] and)
      (VP (VBP:[1240..1244] have)
        (VP (VBN:[1246..1256] identified) (CC:[1257..1260] and)
            (VBN:[1261..1272] prioritized)
          (NP
            (NP (NN:[1273..1282] candidate) (NNS:[1283..1288] genes))
            (PP (IN:[1289..1295] within)
              (NP
                (NP (DT:[1296..1300] this) (NN:[1301..1307] region))
                (PP (IN:[1308..1311] for)
                  (NP (JJ:[1312..1319] further) (NNS:[1321..1329] analyses)))))))))
    (.:[1329..1330] .)))

;section 11 Span:1331..1362
;Copyright 2000 Wiley-Liss, Inc.
(SEC
  (FRAG (NN:[1331..1340] Copyright) (CD:[1341..1345] 2000)
        (NNP:[1346..1351] Wiley) (HYPH:[1351..1352] -) (NNP:[1352..1356] Liss)
        (,:[1356..1357] ,) (NNP:[1358..1362] Inc.)))

;section 12 Span:1366..1411
;PMID: 11107105 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1366..1370] PMID) (::[1370..1371] :) (CD:[1372..1380] 11107105)
        (NN:[1381..1382] -LSB-) (NNP:[1382..1388] PubMed) (::[1389..1390] -)
        (NN:[1391..1398] indexed) (IN:[1399..1402] for)
        (NNP:[1403..1411] MEDLINE-RSB-)))
